Amicis Research Center
Vacaville, California 95687
0 studies enrolling now · 3 studies all time
What they study most
Calcific Uremic Arteriolopathy, Calciphylaxis, Diabetes Complications, Diabetes Mellitus, Diabetic Nephropathies, End Stage Kidney Disease, Endocrine System Diseases, Glomerulonephritis, Glomerulosclerosis, Focal Segmental, Kidney Diseases, Nephritis, Nephrosis
Studies at this site
- Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD) — Recruiting now
- Phase 3 Study of SNF472 for Calciphylaxis — Completed
- A Study of TRPC5 Channel Inhibitor in Patients With Diabetic Nephropathy, Focal Segmental Glomerulosclerosis, and Treatment-Resistant Minimal Change Disease — Stopped early